18 hasil untuk "Neel, Dylan"
Menampilkan 1–18 · 0,91 detik · RSS
-
Artikel Jurnal Teks lengkap
Timing of First-in-Child Trials of FDA Approved Oncology Drugs
AIM: The lag time between initial human studies of oncology agents to the first-in-child clinical trials of these agents has not been defined. METHODS: We conducted a systematic analysis of time from first-in-human trials to first-in-child trials (age of eligibility of < 18 years) of agents first…
-
Artikel Jurnal Teks lengkap
Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis
In the central nervous system (CNS), execution of programmed cell death (PCD) is crucial for proper neurodevelopment. However, aberrant activation of these pathways in adult CNS leads to neurodegenerative diseases including Amyotrophic Lateral Sclerosis (ALS). How a cell dies is critical, as it can…
-
Artikel Jurnal Teks lengkap
Recent discoveries and applications involving small-molecule microarrays
High-throughput and unbiased binding assays have proven useful in probe discovery for a myriad of biomolecules, including targets of unknown structure or function and historically challenging target classes. Over the past decade, a number of novel formats for executing large-scale binding assays…
-
Artikel Jurnal Teks lengkap
Sponsorship of oncology clinical trials in the United States according to age of eligibility
BACKGROUND: The sponsorship mix of trials relevant to young people with cancer has not been reported. Understanding this sponsorship mix may have implications for policies and regulations related to pediatric cancer drug development. METHODS: We analyzed sponsorship of interventional trials first…
-
Artikel Jurnal Teks lengkap
Landscape of phase 1 clinical trials for minors with cancer in the United States
OBJECTIVES: Understanding trends in characteristics of early phase trials that allow minors with cancer to participate may inform additional efforts to improve cancer drug development for young people. METHODS: We accessed data for oncology phase 1 or phase 1/2 trials in the United States from…
-
Artikel Jurnal Teks lengkap
Gasdermin D is activated but does not drive neurodegeneration in SOD1 (G93A) model of ALS: Implications for targeting pyroptosis
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron loss, microgliosis, and neuroinflammation. While pyroptosis, an inflammatory form of programmed cell death, has been implicated in ALS, the specific role of Gasdermin D (GSDMD) – the…
-
Artikel Jurnal Teks lengkap
Derivation and validation of a risk classification tree for patients with synovial sarcoma
BACKGROUND: Synovial sarcoma (SS) accounts for 8%–10% of all soft‐tissue sarcomas. Clinical presentation and outcomes vary, yet discrete risk groups based on validated prognostic indices are not defined for the full spectrum of patients with SS. METHODS: We performed a retrospective cohort study…
-
Artikel Jurnal Teks lengkap
Gasdermin D is activated but does not drive neurodegeneration in SOD1(G93A) model of ALS: Implications for targeting pyroptosis
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron loss, microgliosis, and neuroinflammation. While pyroptosis, an inflammatory form of programmed cell death, has been implicated in ALS, the specific role of Gasdermin D (GSDMD) - the…
-
Artikel Jurnal Teks lengkap
Nociceptive Sensory Neurons Mediate Inflammation Induced by Bacillus Anthracis Edema Toxin
Bacterial products are able to act on nociceptive neurons during pathogenic infection. Neurogenic inflammation is an active part of pain signaling and has recently been shown to impact host-pathogen defense. Bacillus anthracis Edema Toxin (ET) produces striking edema in peripheral tissues, but the…
-
Artikel Jurnal Teks lengkap
Real‐World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States
INTRODUCTION/AIMS: Sodium phenylbutyrate (PB) and taurursodiol (TURSO)—PB and TURSO—was approved as a treatment for amyotrophic lateral sclerosis (ALS) in the United States in 2022 based on the results of a phase 2 trial, but was voluntarily withdrawn from the market in 2024 after negative results…
-
Artikel Jurnal Teks lengkap
Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion
The meninges are densely innervated by nociceptive sensory neurons that mediate pain and headache(1,2). Bacterial meningitis causes life-threatening infections of the meninges and central nervous system, affecting more than 2.5 million people a year(3–5). How pain and neuroimmune interactions…
-
Artikel Jurnal Teks lengkap
An Advanced Cardiac Life Support Application Improves Performance during Simulated Cardiac Arrest
Objectives Variability in cardiopulmonary arrest training and management leads to inconsistent outcomes during in-hospital cardiac arrest. Existing clinical decision aids, such as American Heart Association (AHA) advanced cardiovascular life support (ACLS) pocket cards and third-party mobile apps…
-
Artikel Jurnal Teks lengkap
VLDLR and ApoER2 are receptors for multiple alphaviruses
Alphaviruses, like many other arthropod-borne viruses, infect vertebrate species and insect vectors separated by hundreds of millions of years of evolutionary history. Entry into evolutionarily divergent host cells can be accomplished by recognition of different cellular receptors in different…
-
Artikel Jurnal Teks lengkap
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis
AIMS: RNS60 is an investigational product in clinical development for amyotrophic lateral sclerosis (ALS). RNS60 slowed disease progression in the ALS SOD1(G93A) mouse model and was safe and well tolerated both in an open‐label pilot study and a randomized, placebo‐controlled, multicenter phase 2…
-
Artikel Jurnal Teks lengkap
Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration
Mitochondrial dysfunction and axon loss are hallmarks of neurologic diseases. Gasdermin (GSDM) proteins are executioner pore-forming molecules that mediate cell death, yet their roles in the central nervous system (CNS) are not well understood. Here, we find that one GSDM family member, GSDME is…
-
Artikel Jurnal Teks lengkap
CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model
Astrocytes promote neuroinflammation and neurodegeneration in multiple sclerosis (MS) through cell-intrinsic activities and their ability to recruit and activate other cell types. In a genome-wide CRISPR-based forward genetic screen investigating regulators of astrocyte proinflammatory responses…
-
Artikel Jurnal Teks lengkap
Nociceptor neurons direct goblet cells via a CGRP-RAMP1 axis to drive mucus production and gut barrier protection
Neuroepithelial crosstalk is critical for gut physiology. However, the mechanisms by which sensory neurons communicate with epithelial cells to mediate gut barrier protection at homeostasis and during inflammation are not well understood. Here, we find that Nav1.8(+)CGRP(+) nociceptor neurons are…
-
Artikel Jurnal Teks lengkap
Anthrax toxins regulate pain signaling and can deliver molecular cargoes into Antxr2(+) DRG sensory neurons
Bacterial products can act on neurons to alter signaling and function. Here, we find that dorsal root ganglia (DRG) sensory neurons are enriched for ANTXR2, the high-affinity receptor for anthrax toxins. Anthrax toxins are composed of protective antigen (PA), which binds to ANTXR2, and the protein…